+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
In Vitro Diagnostics Market Report 2025-2035- Product Image
In Vitro Diagnostics Market Report 2025-2035- Product Image
New

In Vitro Diagnostics Market Report 2025-2035

  • PDF Icon

    Report

  • 356 Pages
  • June 2025
  • Region: Global
  • Visiongain
  • ID: 6010612
Description Jump to:
Overall world revenue for the In Vitro Diagnostics Market: In terms of value the market will surpass US$95 billion in 2025, the work calculates. The publisher predicts strong revenue growth through to 2035. The work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

The In Vitro Diagnostics Market Report 2025-2035 (Including Impact of U.S. Trade Tariffs): This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Technological Advancements Propelling Industry Growth

The in-vitro diagnostics (IVD) sector continues to experience significant growth, propelled by advancements in diagnostic technologies that enhance precision, portability, and affordability. A notable milestone was achieved in May 2025 when the U.S. Food and Drug Administration (FDA) approved the first blood test to aid in diagnosing Alzheimer's disease. This approval is expected to improve early detection and management of Alzheimer's disease, particularly benefiting the aging population .

In parallel, the oncology diagnostics landscape is being transformed by the adoption of blood-based tests for detecting minimal residual disease (MRD). Companies such as Guardant Health, Natera, and Exact Sciences are at the forefront of this revolution, utilising circulating tumour DNA to identify cancer recurrences much earlier than conventional imaging methods. These advancements enable more timely interventions and personalised treatment strategies, marking a significant shift in cancer care.

Segment Analysis

As of 2025, the reagents segment maintains its dominance in the IVD market, accounting for over 60% of the market share. This segment is projected to exhibit the highest compound annual growth rate (CAGR) through 2035, driven by continuous innovation and the development of novel diagnostic reagents and kits. A recent example includes the FDA's clearance of Werfen's Aptiva reagents for enhanced autoimmune diagnostics. These reagents offer improved specificity and efficiency in detecting autoimmune diseases, reflecting the industry's commitment to advancing diagnostic accuracy.

Furthermore, the demand for personalised medicine is fuelling the growth of companion diagnostics. This comprehensive test provides insights into a wide array of genetic alterations, aiding clinicians in selecting targeted therapies for cancer patients. The integration of such advanced diagnostics into clinical practice underscores the critical role of reagents in enabling precision medicine.

As the IVD industry continues to evolve, investments in research and development of innovative reagents and diagnostic tools remain pivotal. Companies focusing on these areas are well-positioned to lead in the competitive landscape, addressing emerging healthcare needs with cutting-edge solutions.

What would be the Impact of US Trade Tariffs on the Global In Vitro Diagnostics Market?

The influence of U.S. trade tariffs on the global In Vitro Diagnostics (IVD) market can be substantial, affecting cost structures and supply chain dynamics across various regions. A multitude of in vitro diagnostic (IVD) products, encompassing reagents, analysers, and components, are imported into the United States from nations such as China, Germany, and Japan. Tariffs on these imports can increase the cost of goods sold for U.S.-based diagnostics firms, potentially compressing profit margins or resulting in elevated prices for healthcare providers and patients.

The global ripple effect encompasses supply chain realignment, as companies may relocate sourcing or manufacturing to tariff-exempt nations, thereby augmenting operational complexity and expenses. Moreover, uncertainty surrounding tariffs may postpone investments in innovation or international collaborations, especially for small and medium-sized IVD companies dependent on global partnerships. In areas such as the EU and Asia-Pacific, this could create opportunities to enhance domestic production or secure a competitive advantage in exports to non-U.S. markets. In the long term, enduring tariffs may expedite localisation strategies, cultivate regional alliances, and transform the competitive dynamics of the global IVD industry.

Key Questions Answered

  • How is the in vitro diagnostics market evolving?
  • What is driving and restraining the in vitro diagnostics market?
  • How will each in vitro diagnostics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2035?
  • How will the market shares for each in vitro diagnostics submarket develop from 2025 to 2035?
  • What will be the main driver for the overall market from 2025 to 2035?
  • Will leading in vitro diagnostics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2035 and which geographical region will lead the market in 2035?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the in vitro diagnostics projects for these leading companies?
  • How will the industry evolve during the period between 2025 and 2035?
  • What are the implications of
in vitro diagnostics projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the in vitro diagnostics market?
  • Where is the in vitro diagnostics market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the in vitro diagnostics market today, and over the next 10 years:

  • This 356-page report provides 125 tables, 212 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2035 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2035, the new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter's Five Forces Analysis, PEST Analysis and recent developments.

Segments Covered in the Report

Product

  • Instruments
  • Reagents & Kits

Test

  • Clinical Chemistry
  • Immunoassay/Immunochemistry
  • Molecular Diagnostics
  • Hematology
  • Urinalysis
  • Others

Application

  • Cardiology
  • Diabetes
  • Oncology
  • Infectious Diseases
  • Nephrology
  • Autoimmune Diseases
  • Drug Testing/Pharmacogenomics
  • Others

End-users

  • Academic & Research Institutes
  • Diagnostic Laboratories
  • Hospitals
  • Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA
The report also includes profiles for some of the leading companies in the In Vitro Diagnostics Market, with a focus on this segment of these companies'operations.

Leading companies and the potential for market growth

  • QIAGEN
  • BD
  • BioM√©rieux
  • F. Hoffmann-La Roche, Ltd.
  • Quidel
  • Ortho Corporation
  • Abbott
  • Agilent Technologies, Inc.
  • Thermofisher Scientific, Inc.
  • Siemens Healthineers AG
  • Bio-Rad Laboratories, Inc.
  • Danaher
  • Sysmex Corporation
  • Charles River Laboratories
  • Quest Diagnostics Incorporated
  • Illumina, Inc.
  • Hologic
  • Revvity
  • Exact Sciences

How will the In Vitro Diagnostics Market report help you?

In summary, the 350+ page report provides you with the following knowledge:
  • Revenue forecasts to 2035 for In Vitro Diagnostics Market 2025 to 2035, with forecasts for Product, Test, Application, and End-users, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2035 for five regional and 20 key national markets - See forecasts for the In Vitro Diagnostics Market market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 19 of the major companies involved in the In Vitro Diagnostics Market.
Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. This study is for everybody needing commercial analyses for the In Vitro Diagnostics Market 2025 to 2035, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to In Vitro Diagnostics Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About the Publisher
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.3 Impact Analysis
3.3.1 Market Driving Factors
3.3.1.1 Introduction of Technologically Advanced Products
3.3.1.2 Rise in Geriatric Population
3.3.1.3 Increasing Demand of PoC Testing
3.3.2 Market Restraining Factors
3.3.2.1 High Cost of Diagnostic Equipment
3.3.2.2 Stringent Regulatory Requirements in IVD
3.3.3 Market Opportunities
3.3.3.1 Improvement in Immunoassay Diagnostic Technologies
3.3.3.2 Expansion in Emerging Markets
3.3.3.3 Growth of Home-based and Point-of-Care Testing
3.4 U.S. Tariffs: What's the Impact on Global In Vitro Diagnostics Market?
3.4.1 Overview
3.4.2 V-Shaped Recovery Scenario
3.4.3 Why V-Shaped Recovery?
3.4.3.1 Impact from Tariffs
3.4.3.2 Market Dynamics and Demand Recovery
3.4.3.3 Policy and Funding Support
3.4.3.4 Timeframe for Recovery
3.4.4 U-Shaped Recovery Scenario
3.4.4.1 Why U-Shaped Recovery?
3.4.4.2 Impact from Tariffs
3.4.4.3 Market Dynamics and Demand Recovery
3.4.4.4 Policy and Funding Support
3.4.4.5 Timeframe for Recovery
3.4.5 L Shaped Recovery Scenario
3.4.5.1 Why L-Shaped Recovery?
3.4.5.2 Impact from Tariffs
3.4.5.3 Market Dynamics and Demand Recovery
3.4.5.4 Policy and Funding Support
3.4.5.5 Timeframe for Recovery
3.4.6 What Strategic Considerations Should Clients Factor into Their Near-term (2025-2030) and Long-term (2025-2035) Planning?
3.4.7 Impact of U.S. and China Trade War on In Vitro Diagnostics Market
3.4.8 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
3.4.9 Sensitivity Mapping for the Trade Tariff Impact
3.5 Porter's Five Forces Analysis
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Competitive Rivalry
3.5.4 Threat of Substitutes
3.5.5 Threat of New Entrants
3.6 PEST Analysis
3.6.1 Political
3.6.2 Economical
3.6.3 Social
3.6.4 Technological
3.7 Impact of Trump Tariffs on In Vitro Diagnostics Market
3.7.1 Trade Barriers and Supply Chain Disruption
3.7.2 Cost Implications for U.S. and Global Manufacturers
3.7.3 Policy Uncertainty and Investment Hesitation
4 In Vitro Diagnostics Market Analysis by Product
4.1 Key Findings
4.2 Product Segment: Market Attractiveness Index
4.3 In Vitro Diagnostics Market Size Estimation and Forecast by Product
4.4 Instruments
4.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.4.2 Market Share by Region, 2025 & 2035 (%)
4.5 Reagents & Kits
4.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
4.5.2 Market Share by Region, 2025 & 2035 (%)
5 In Vitro Diagnostics Market Analysis by Test
5.1 Key Findings
5.2 Test Segment: Market Attractiveness Index
5.3 In Vitro Diagnostics Market Size Estimation and Forecast by Test
5.4 Clinical Chemistry
5.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.4.2 Market Share by Region, 2025 & 2035 (%)
5.5 Immunoassay/Immunochemistry
5.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.5.2 Market Share by Region, 2025 & 2035 (%)
5.6 Molecular Diagnostics
5.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.6.2 Market Share by Region, 2025 & 2035 (%)
5.7 Haematology
5.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.7.2 Market Share by Region, 2025 & 2035 (%)
5.8 Urinalysis
5.8.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.8.2 Market Share by Region, 2025 & 2035 (%)
5.9 Others
5.9.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
5.9.2 Market Share by Region, 2025 & 2035 (%)
6 In Vitro Diagnostics Market Analysis by Application
6.1 Key Findings
6.2 Application Segment: Market Attractiveness Index
6.3 In Vitro Diagnostics Market Size Estimation and Forecast by Application
6.4 Cardiology
6.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.4.2 Market Share by Region, 2025 & 2035 (%)
6.5 Diabetes
6.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.5.2 Market Share by Region, 2025 & 2035 (%)
6.6 Oncology
6.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.6.2 Market Share by Region, 2025 & 2035 (%)
6.7 Infectious Diseases
6.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.7.2 Market Share by Region, 2025 & 2035 (%)
6.8 Maternal Disorders
6.8.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.8.2 Market Share by Region, 2025 & 2035 (%)
6.9 Mobility Disorders
6.9.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.9.2 Market Share by Region, 2025 & 2035 (%)
6.10 Autoimmune Diseases
6.10.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.10.2 Market Share by Region, 2025 & 2035 (%)
6.11 Drug Testing/Pharmacogenomics
6.11.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.11.2 Market Share by Region, 2025 & 2035 (%)
6.12 Others
6.12.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
6.12.2 Market Share by Region, 2025 & 2035 (%)
7 In Vitro Diagnostics Market Analysis by End-users
7.1 Key Findings
7.2 End-users Segment: Market Attractiveness Index
7.3 In Vitro Diagnostics Market Size Estimation and Forecast by End-users
7.4 Academic & Research Institutes
7.4.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
7.4.2 Market Share by Region, 2025 & 2035 (%)
7.5 Diagnostic Laboratories
7.5.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
7.5.2 Market Share by Region, 2025 & 2035 (%)
7.6 Hospitals
7.6.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
7.6.2 Market Share by Region, 2025 & 2035 (%)
7.7 Others
7.7.1 Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
7.7.2 Market Share by Region, 2025 & 2035 (%)
8 In Vitro Diagnostics Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast
9 North America In Vitro Diagnostics Market Analysis
9.1 Key Findings
9.2 North America In Vitro Diagnostics Market Attractiveness Index
9.3 North America In Vitro Diagnostics Market by Country, 2025, 2030 & 2035 (US$ Billion)
9.4 North America In Vitro Diagnostics Market Size Estimation and Forecast by Country
9.5 North America In Vitro Diagnostics Market Size Estimation and Forecast by Product
9.6 North America In Vitro Diagnostics Market Size Estimation and Forecast by Test
9.7 North America In Vitro Diagnostics Market Size Estimation and Forecast by Application
9.8 North America In Vitro Diagnostics Market Size Estimation and Forecast by End-users
9.9 U.S. In Vitro Diagnostics Market Analysis
9.10 Canada In Vitro Diagnostics Market Analysis
10 Europe In Vitro Diagnostics Market Analysis
10.1 Key Findings
10.2 Europe In Vitro Diagnostics Market Attractiveness Index
10.3 Europe In Vitro Diagnostics Market by Country, 2025, 2030 & 2035 (US$ Billion)
10.4 Europe In Vitro Diagnostics Market Size Estimation and Forecast by Country
10.5 Europe In Vitro Diagnostics Market Size Estimation and Forecast by Product
10.6 Europe In Vitro Diagnostics Market Size Estimation and Forecast by Test
10.7 Europe In Vitro Diagnostics Market Size Estimation and Forecast by Application
10.8 Europe In Vitro Diagnostics Market Size Estimation and Forecast by End-users
10.9 Germany In Vitro Diagnostics Market Analysis
10.10 UK In Vitro Diagnostics Market Analysis
10.11 France In Vitro Diagnostics Market Analysis
10.12 Italy In Vitro Diagnostics Market Analysis
10.13 Spain In Vitro Diagnostics Market Analysis
10.14 Rest of Europe In Vitro Diagnostics Market Analysis
11 Asia Pacific In Vitro Diagnostics Market Analysis
11.1 Key Findings
11.2 Asia Pacific In Vitro Diagnostics Market Attractiveness Index
11.3 Asia Pacific In Vitro Diagnostics Market by Country, 2025, 2030 & 2035 (US$ Billion)
11.4 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by Country
11.5 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by Product
11.6 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by Test
11.7 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by Application
11.8 Asia Pacific In Vitro Diagnostics Market Size Estimation and Forecast by End-users
11.9 Japan In Vitro Diagnostics Market Analysis
11.10 China In Vitro Diagnostics Market Analysis
11.11 India In Vitro Diagnostics Market Analysis
11.12 Australia In Vitro Diagnostics Market Analysis
11.13 Rest of Asia Pacific In Vitro Diagnostics Market Analysis
12 Latin America In Vitro Diagnostics Market Analysis
12.1 Key Findings
12.2 Latin America In Vitro Diagnostics Market Attractiveness Index
12.3 Latin America In Vitro Diagnostics Market by Country, 2025, 2030 & 2035 (US$ Billion)
12.4 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by Country
12.5 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by Product
12.6 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by Test
12.7 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by Application
12.8 Latin America In Vitro Diagnostics Market Size Estimation and Forecast by End-users
12.9 Brazil In Vitro Diagnostics Market Analysis
12.10 Mexico In Vitro Diagnostics Market Analysis
12.11 Rest of Latin America In Vitro Diagnostics Market Analysis
13 MEA In Vitro Diagnostics Market Analysis
13.1 Key Findings
13.2 MEA In Vitro Diagnostics Market Attractiveness Index
13.3 MEA In Vitro Diagnostics Market by Country, 2025, 2030 & 2035 (US$ Billion)
13.4 MEA In Vitro Diagnostics Market Size Estimation and Forecast by Country
13.5 MEA In Vitro Diagnostics Market Size Estimation and Forecast by Product
13.6 MEA In Vitro Diagnostics Market Size Estimation and Forecast by Test
13.7 MEA In Vitro Diagnostics Market Size Estimation and Forecast by Application
13.8 MEA In Vitro Diagnostics Market Size Estimation and Forecast by End-users
13.9 GCC In Vitro Diagnostics Market Analysis
13.10 South Africa In Vitro Diagnostics Market Analysis
13.11 Rest of MEA In Vitro Diagnostics Market Analysis
14 Company Profiles
14.1 QIAGEN
14.1.1 Company Snapshot
14.1.2 Company Overview
14.1.3 Financial Analysis
14.1.3.1 Net Revenue, 2020-2024
14.1.3.2 R&D, 2020-2024
14.1.3.3 Regional Market Shares, 2024
14.1.3.4 Business Segment Market Shares, 2024
14.1.4 Product Benchmarking
14.1.5 SWOT Analysis
14.1.6 Strategic Outlook
14.2 BD
14.2.1 Company Snapshot
14.2.2 Company Overview
14.2.3 Financial Analysis
14.2.3.1 Net Revenue, 2020-2024
14.2.3.2 R&D, 2020-2024
14.2.3.3 Business Segment Market Shares, 2024
14.2.4 Product Benchmarking
14.2.5 SWOT Analysis
14.3 BIOMvâRIEUX
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Net Revenue, 2020-2024
14.3.3.2 R&D, 2020-2024
14.3.3.3 Regional Market Shares, 2024
14.3.4 Product Benchmarking
14.3.5 SWOT Analysis
14.3.6 Strategic Outlook
14.4 F. Hoffmann-La Roche, Ltd.
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Net Revenue, 2020-2024
14.4.3.2 R&D, 2020-2024
14.4.3.3 Business Segment Market Shares, 2024
14.4.4 Product Benchmarking
14.4.5 SWOT Analysis
14.4.6 Strategic Outlook
14.5 QuidelOrtho Corporation
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Financial Analysis
14.5.3.1 Net Revenue, 2020-2024
14.5.3.2 R&D, 2020-2024
14.5.3.3 Regional Market Shares, 2024
14.5.3.4 Business Segment Market Shares, 2024
14.5.4 Product Benchmarking
14.5.5 SWOT Analysis
14.5.6 Strategic Outlook
14.6 Abbott
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Financial Analysis
14.6.3.1 Net Revenue, 2020-2024
14.6.3.2 R&D, 2020-2024
14.6.3.3 Regional Market Shares, 2024
14.6.3.4 Business Segment Market Shares, 2024
14.6.4 Product Benchmarking
14.7 Agilent Technologies, Inc.
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Net Revenue, 2020-2024
14.7.3.2 R&D, 2020-2024
14.7.3.3 Regional Market Shares, 2024
14.7.3.4 Business Segment Market Shares, 2024
14.7.4 Product Benchmarking
14.7.5 Strategic Outlook
14.8 Thermofisher Scientific, Inc.
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Financial Analysis
14.8.3.1 Net Revenue, 2020-2024
14.8.3.2 R&D, 2020-2024
14.8.3.3 Regional Market Shares, 2024
14.8.3.4 Business Segment Market Shares, 2024
14.8.4 Product Benchmarking
14.8.5 Strategic Outlook
14.9 Siemens Healthineers AG
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Financial Analysis
14.9.3.1 Net Revenue, 2020-2024
14.9.3.2 Regional Market Shares, 2024
14.9.3.3 Business Segment Market Shares, 2024
14.9.4 Product Benchmarking
14.9.5 Strategic Outlook
14.10 Bio-Rad Laboratories, Inc.
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Financial Analysis
14.10.3.1 Net Revenue, 2020-2024
14.10.3.2 Regional Market Shares, 2024
14.10.3.3 Business Segment Market Shares, 2024
14.10.4 Product Benchmarking
14.10.5 Strategic Outlook
14.11 Danaher
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Financial Analysis
14.11.3.1 Net Revenue, 2020-2024
14.11.3.2 R&D, 2020-2024
14.11.3.3 Regional Market Shares, 2024
14.11.3.4 Business Segment Market Shares, 2024
14.11.4 Product Benchmarking
14.11.5 Strategic Outlook
14.12 Sysmex Corporation
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Financial Analysis
14.12.3.1 Net Revenue, 2020-2024
14.12.3.2 R&D, 2020-2024
14.12.4 Product Benchmarking
14.12.5 Strategic Outlook
14.13 Charles River Laboratories
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Financial Analysis
14.13.3.1 Net Revenue, 2020-2024
14.13.3.2 Regional Market Shares, 2024
14.13.3.3 Business Segment Market Shares, 2024
14.13.4 Services Benchmarking
14.14 Quest Diagnostics Incorporated
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Financial Analysis
14.14.3.1 Net Revenue, 2020-2024
14.14.3.2 Business Segment Market Shares, 2024
14.14.4 Product Benchmarking
14.14.5 Strategic Outlook
14.15 Illumina, Inc.
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.3.1 Net Revenue, 2020-2024
14.15.3.2 R&D, 2020-2024
14.15.3.3 Regional Market Shares, 2024
14.15.3.4 Business Segment Market Shares, 2024
14.15.4 Product Benchmarking
14.15.5 Strategic Outlook
14.16 Hologic
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Financial Analysis
14.16.3.1 Net Revenue, 2020-2024
14.16.3.2 R&D, 2020-2024
14.16.3.3 Regional Market Shares, 2024
14.16.3.4 Business Segment Market Shares, 2024
14.16.4 Product Benchmarking
14.16.5 Strategic Outlook
14.17 Exact Sciences
14.17.1 Company Snapshot
14.17.2 Company Overview
14.17.3 Financial Analysis
14.17.3.1 Net Revenue, 2020-2024
14.17.3.2 R&D, 2020-2024
14.17.3.3 Regional Market Shares, 2024
14.17.4 Product Benchmarking
14.18 Revvity
14.18.1 Company Snapshot
14.18.2 Company Overview
14.18.3 Financial Analysis
14.18.3.1 Net Revenue, 2020-2024
14.18.3.2 R&D, 2020-2024
14.18.4 Product Benchmarking
14.18.5 Strategic Outlook
15 Conclusion and Recommendations
15.1 Concluding Remarks
15.2 Recommendations for Market Players
List of Tables
Table 1 In Vitro Diagnostics Market Snapshot, 2025 & 2035 (US$ Billion, CAGR %)
Table 2 In Vitro Diagnostics Market: International Trade Tariff Impact Recovery Scenarios Snapshot
Table 3 In Vitro Diagnostics Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): "V" Shaped Recovery
Table 4 In Vitro Diagnostics Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): "U" Shaped Recovery
Table 5 In Vitro Diagnostics Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%): "L" Shaped Recovery
Table 6 In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 7 Instruments Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 8 Reagents & Kits Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 9 In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 10 Clinical Chemistry Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 11 Immunoassay/Immunochemistry Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 12 Molecular Diagnostics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 13 Haematology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 14 Urinalysis Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 15 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 16 In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 17 Cardiology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 18 Diabetes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 19 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 20 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 21 Maternal Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 22 Mobility Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 23 Autoimmune Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 24 Drug Testing/Pharmacogenomics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 25 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 26 Diagnostic Segment Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 27 Academic & Research Institutes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 28 Diagnostic Laboratories Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 29 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 30 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 31 In Vitro Diagnostics Market Forecast by Region, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 32 North America In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 33 North America In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 34 North America In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 35 North America In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 36 North America In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 37 U.S. In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 38 Canada In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 39 Europe In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 40 Europe In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 41 Europe In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 42 Europe In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 43 Europe In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 44 Germany In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 45 UK In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 46 France In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 47 Italy In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 48 Spain In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 49 Rest of Europe In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 50 Asia Pacific In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 51 Asia Pacific In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 52 Asia Pacific In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 53 Asia Pacific In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 54 Asia Pacific In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 55 Japan In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 56 China In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 57 India In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 58 Australia In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 59 Rest of Asia Pacific In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 60 Latin America In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 61 Latin America In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 62 Latin America In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 63 Latin America In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 64 Latin America In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 65 Brazil In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 66 Mexico In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 67 Rest of Latin America In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 68 MEA In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 69 MEA In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 70 MEA In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 71 MEA In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 72 MEA In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR%, CAGR%)
Table 73 GCC Home Healthcare Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 74 South Africa Home Healthcare Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 75 Rest of MEA Home Healthcare Market Forecast, 2025-2035 (US$ Billion, AGR %, CAGR %)
Table 76 QIAGEN: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 77 QIAGEN: Product Benchmarking
Table 78 QIAGEN: SWOT Analysis
Table 79 QIAGEN: Strategic Outlook
Table 80 BD: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 81 BD: Product Benchmarking
Table 82 BD: SWOT Analysis
Table 83 BIOMvâRIEUX: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 84 BIOMvâRIEUX: Product Benchmarking
Table 85 BIOMvâRIEUX: SWOT Analysis
Table 86 BIOMvâRIEUX: Strategic Outlook
Table 87 F. Hoffmann-La Roche, Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 F. Hoffmann-La Roche, Ltd.: Product Benchmarking
Table 89 F. Hoffmann-La Roche, Ltd.: SWOT Analysis
Table 90 F. Hoffmann-La Roche, Ltd.: Strategic Outlook
Table 91 QuidelOrtho Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 QuidelOrtho Corporation: Product Benchmarking
Table 93 QuidelOrtho Corporation: SWOT Analysis
Table 94 QuidelOrtho Corporation: Strategic Outlook
Table 95 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Abbott: Product Benchmarking
Table 97 Agilent Technologies, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Agilent Technologies, Inc.: Product Benchmarking
Table 99 Agilent Technologies, Inc.: Strategic Outlook
Table 100 Thermofisher Scientific, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Thermofisher Scientific, Inc.: Product Benchmarking
Table 102 Thermofisher Scientific, Inc.: Strategic Outlook
Table 103 Siemens Healthineers AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Siemens Healthineers AG: Product Benchmarking
Table 105 Siemens Healthineers AG: Strategic Outlook
Table 106 Bio-Rad Laboratories, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Bio-Rad Laboratories, Inc.: Product Benchmarking
Table 108 Bio-Rad Laboratories, Inc.: Strategic Outlook
Table 109 Danaher: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Danaher: Product Benchmarking
Table 111 Danaher: Strategic Outlook
Table 112 Sysmex Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 Sysmex Corporation: Product Benchmarking
Table 114 Sysmex Corporation: Strategic Outlook
Table 115 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 Charles River Laboratories: Services Benchmarking
Table 117 Quest Diagnostics Incorporated: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 118 Quest Diagnostics Incorporated: Product Benchmarking
Table 119 Quest Diagnostics Incorporated: Strategic Outlook
Table 120 Illumina, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 121 Illumina, Inc.: Product Benchmarking
Table 122 Illumina, Inc.: Strategic Outlook
Table 123 Hologic: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 Hologic: Product Benchmarking
Table 125 Hologic: Strategic Outlook
Table 126 Exact Sciences: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 127 Exact Sciences: Product Benchmarking
Table 128 Revvity: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 129 Revvity: Product Benchmarking
Table 130 Revvity: Strategic Outlook
List of Figures
Figure 1 In Vitro Diagnostics Market Segmentation
Figure 2 In Vitro Diagnostics Market by Product: Market Attractiveness Index
Figure 3 In Vitro Diagnostics Market by Test: Market Attractiveness Index
Figure 4 In Vitro Diagnostics Market by Application: Market Attractiveness Index
Figure 5 In Vitro Diagnostics Market by End-users: Market Attractiveness Index
Figure 6 In Vitro Diagnostics Market Attractiveness Index by Region
Figure 7 In Vitro Diagnostics Market: Market Dynamics
Figure 8 In Vitro Diagnostics Market: Impact Analysis
Figure 9 In Vitro Diagnostics Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: V-Shaped Recovery Scenario
Figure 10 In Vitro Diagnostics Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: U-Shaped Recovery Scenario
Figure 11 In Vitro Diagnostics Market by Region, 2025-2035 (US$ Billion, AGR %), Tariff Impact: L-Shaped Recovery Scenario
Figure 12 Short Term & Long Term Planning
Figure 13 Impact of U.S. and China Trade War
Figure 14 Most Impacted Countries
Figure 15 Sensitivity Mapping for Tariff Impact
Figure 16 In Vitro Diagnostics Market: Porter's Five Forces Analysis
Figure 17 In Vitro Diagnostics Market: PEST Analysis
Figure 18 In Vitro Diagnostics Market Attractiveness Index by Product
Figure 19 In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 20 In Vitro Diagnostics Market Share Forecast by Product, 2025, 2030, 2035 (%)
Figure 21 Instruments Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 22 Instruments Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 23 Reagents & Kits Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 24 Reagents & Kits Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 25 In Vitro Diagnostics Market Attractiveness Index by Product
Figure 26 In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
Figure 27 In Vitro Diagnostics Market Share Forecast by Test, 2025, 2030, 2035 (%)
Figure 28 Clinical Chemistry Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 29 Clinical Chemistry Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 30 Immunoassay/Immunochemistry Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 31 Immunoassay/Immunochemistry Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 32 Molecular Diagnostics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 33 Molecular Diagnostics Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 34 Haematology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 35 Haematology Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 36 Urinalysis Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 37 Urinalysis Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 38 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 39 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 40 In Vitro Diagnostics Market Attractiveness Index by Application
Figure 41 In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 42 In Vitro Diagnostics Market Share Forecast by Application, 2025, 2030, 2035 (%)
Figure 43 Cardiology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 44 Cardiology Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 45 Diabetes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 46 Diabetes Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 47 Oncology Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 48 Oncology Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 49 Infectious Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 50 Infectious Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 51 Maternal Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 52 Maternal Disorders Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 53 Mobility Disorders Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 54 Mobility Disorders Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 55 Autoimmune Diseases Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 56 Autoimmune Diseases Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 57 Drug Testing/Pharmacogenomics Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 58 Drug Testing/Pharmacogenomics Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 59 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 60 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 61 In Vitro Diagnostics Market Attractiveness Index by End-users
Figure 62 In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 63 In Vitro Diagnostics Market Share Forecast by End-users, 2025, 2030, 2035 (%)
Figure 64 Academic & Research Institutes Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 65 Academic & Research Institutes Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 66 Diagnostic Laboratories Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 67 Diagnostic Laboratories Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 68 Hospitals Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 69 Hospitals Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 70 Others Segment Market Forecast by Region, 2025-2035 (US$ Billion, AGR %)
Figure 71 Others Segment Market Share Forecast by Region, 2025 & 2035 (%)
Figure 72 In Vitro Diagnostics Market Forecast by Region 2025, 2030, 2035 (Revenue, CAGR%)
Figure 73 In Vitro Diagnostics Market Share Forecast by Region 2025, 2030, 2035 (%)
Figure 74 In Vitro Diagnostics Market by Region, 2025-2035 (US$ Mn)
Figure 75 North America In Vitro Diagnostics Market Attractiveness Index
Figure 76 North America In Vitro Diagnostics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 77 North America In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 78 North America In Vitro Diagnostics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 79 North America In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 80 North America In Vitro Diagnostics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 81 North America In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
Figure 82 North America In Vitro Diagnostics Market Share Forecast by Test, 2025 & 2035 (%)
Figure 83 North America In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 84 North America In Vitro Diagnostics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 85 North America In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 86 North America In Vitro Diagnostics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 87 U.S. In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 88 Canada In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 89 Europe In Vitro Diagnostics Market Attractiveness Index
Figure 90 Europe In Vitro Diagnostics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 91 Europe In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 92 Europe In Vitro Diagnostics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 93 Europe In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 94 Europe In Vitro Diagnostics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 95 Europe In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
Figure 96 Europe In Vitro Diagnostics Market Share Forecast by Test, 2025 & 2035 (%)
Figure 97 Europe In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 98 Europe In Vitro Diagnostics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 99 Europe In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 100 Europe In Vitro Diagnostics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 101 Germany In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 102 UK In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 103 France In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 104 Italy In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 105 Spain In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 106 Rest of Europe In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 107 Asia Pacific In Vitro Diagnostics Market Attractiveness Index
Figure 108 Asia Pacific In Vitro Diagnostics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 109 Asia Pacific In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 110 Asia Pacific In Vitro Diagnostics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 111 Asia Pacific In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 112 Asia Pacific In Vitro Diagnostics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 113 Asia Pacific In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
Figure 114 Asia Pacific In Vitro Diagnostics Market Share Forecast by Test, 2025 & 2035 (%)
Figure 115 Asia Pacific In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 116 Asia Pacific In Vitro Diagnostics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 117 Asia Pacific In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 118 Asia Pacific In Vitro Diagnostics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 119 Japan In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 120 China In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 121 India In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 122 Australia In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 123 Rest of Asia Pacific In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 124 Latin America In Vitro Diagnostics Market Attractiveness Index
Figure 125 Latin America In Vitro Diagnostics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 126 Latin America In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 127 Latin America In Vitro Diagnostics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 128 Latin America In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 129 Latin America In Vitro Diagnostics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 130 Latin America In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
Figure 131 Latin America In Vitro Diagnostics Market Share Forecast by Test, 2025 & 2035 (%)
Figure 132 Latin America In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 133 Latin America In Vitro Diagnostics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 134 Latin America In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 135 Latin America In Vitro Diagnostics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 136 Brazil In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 137 Mexico In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 138 Rest of Latin America In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 139 MEA In Vitro Diagnostics Market Attractiveness Index
Figure 140 MEA In Vitro Diagnostics Market by Region, 2025, 2030 & 2035 (US$ Billion)
Figure 141 MEA In Vitro Diagnostics Market Forecast by Country, 2025-2035 (US$ Billion, AGR %)
Figure 142 MEA In Vitro Diagnostics Market Share Forecast by Country, 2025 & 2035 (%)
Figure 143 MEA In Vitro Diagnostics Market Forecast by Product, 2025-2035 (US$ Billion, AGR %)
Figure 144 MEA In Vitro Diagnostics Market Share Forecast by Product, 2025 & 2035 (%)
Figure 145 MEA In Vitro Diagnostics Market Forecast by Test, 2025-2035 (US$ Billion, AGR %)
Figure 146 MEA In Vitro Diagnostics Market Share Forecast by Test, 2025 & 2035 (%)
Figure 147 MEA In Vitro Diagnostics Market Forecast by Application, 2025-2035 (US$ Billion, AGR %)
Figure 148 MEA In Vitro Diagnostics Market Share Forecast by Application, 2025 & 2035 (%)
Figure 149 MEA In Vitro Diagnostics Market Forecast by End-users, 2025-2035 (US$ Billion, AGR %)
Figure 150 MEA In Vitro Diagnostics Market Share Forecast by End-users, 2025 & 2035 (%)
Figure 151 GCC In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 152 South Africa In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 153 Rest of MEA In Vitro Diagnostics Market Forecast, 2025-2035 (US$ Billion, AGR %)
Figure 154 QIAGEN: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 155 QIAGEN: R&D, 2020-2024 (US$ Million, AGR %)
Figure 156 QIAGEN: Regional Market Shares (%), 2024
Figure 157 QIAGEN: Business Segment Market Shares (%), 2024
Figure 158 BD: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 159 BD: R&D, 2020-2024 (US$ Million, AGR %)
Figure 160 BD: Business Segment Market Shares (%), 2024
Figure 161 BIOMÉRIEUX: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 162 BIOMÉRIEUX: R&D, 2020-2024 (US$ Million, AGR %)
Figure 163 BIOMÉRIEUX: Regional Market Shares (%), 2024
Figure 164 F. Hoffmann-La Roche, Ltd.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 165 F. Hoffmann-La Roche, Ltd.: R&D, 2020-2024 (US$ Million, AGR %)
Figure 166 F. Hoffmann-La Roche, Ltd.: Business Segment Market Shares (%), 2024
Figure 167 QuidelOrtho Corporation: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 168 QuidelOrtho Corporation: R&D, 2020-2024 (US$ Million, AGR %)
Figure 169 QuidelOrtho Corporation: Regional Market Shares (%), 2024
Figure 170 QuidelOrtho Corporation: Business Segment Market Shares (%), 2024
Figure 171 Abbott: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 172 Abbott: R&D, 2020-2024 (US$ Million, AGR %)
Figure 173 Abbott: Regional Market Shares (%), 2024
Figure 174 Abbott: Business Segment Market Shares (%), 2024
Figure 175 Agilent Technologies, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 176 Agilent Technologies, Inc.: R&D, 2020-2024 (US$ Million, AGR %)
Figure 177 Agilent Technologies, Inc.: Regional Market Shares (%), 2024
Figure 178 Agilent Technologies, Inc.: Business Segment Market Shares (%), 2024
Figure 179 Thermofisher Scientific, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 180 Thermofisher Scientific, Inc.: R&D, 2020-2024 (US$ Million, AGR %)
Figure 181 Thermofisher Scientific, Inc.: Regional Market Shares (%), 2024
Figure 182 Thermofisher Scientific, Inc.: Business Segment Market Shares (%), 2024
Figure 183 Siemens Healthineers AG: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 184 Siemens Healthineers AG: Regional Market Shares (%), 2024
Figure 185 Siemens Healthineers AG: Business Segment Market Shares (%), 2024
Figure 186 Bio-Rad Laboratories, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 187 Bio-Rad Laboratories, Inc.: Regional Market Shares (%), 2024
Figure 188 Bio-Rad Laboratories, Inc.: Business Segment Market Shares (%), 2024
Figure 189 Danaher: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 190 Danaher: R&D, 2020-2024 (US$ Million, AGR %)
Figure 191 Danaher: Regional Market Shares (%), 2024
Figure 192 Danaher: Business Segment Market Shares (%), 2024
Figure 193 Sysmex Corporation: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 194 Sysmex Corporation: R&D, 2020-2024 (US$ Million, AGR %)
Figure 195 Charles River Laboratories: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 196 Charles River Laboratories: Regional Market Shares (%), 2024
Figure 197 Charles River Laboratories: Business Segment Market Shares (%), 2024
Figure 198 Quest Diagnostics Incorporated: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 199 Quest Diagnostics Incorporated: Business Segment Market Shares (%), 2024
Figure 200 Illumina, Inc.: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 201 Illumina, Inc.: R&D, 2020-2024 (US$ Million, AGR %)
Figure 202 Illumina, Inc.: Regional Market Shares (%), 2024
Figure 203 Illumina, Inc.: Business Segment Market Shares (%), 2024
Figure 204 Hologic: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 205 Hologic: R&D, 2020-2024 (US$ Million, AGR %)
Figure 206 Hologic: Regional Market Shares (%), 2024
Figure 207 Hologic: Business Segment Market Shares (%), 2024
Figure 208 Exact Sciences: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 209 Exact Sciences: R&D, 2020-2024 (US$ Million, AGR %)
Figure 210 Exact Sciences: Regional Market Shares (%), 2024
Figure 211 Revvity: Net Revenue, 2020-2024 (US$ Million, AGR %)
Figure 212 Revvity: R&D, 2020-2024 (US$ Million, AGR %)

Companies Mentioned

  • Abbott
  • Agilent Technologies, Inc.
  • BD
  • Bio-Rad Laboratories, Inc.
  • BioM√©rieux SA
  • Charles River Laboratories
  • Danaher
  • Exact Sciences
  • F. Hoffmann-La Roche, Ltd.
  • Hologic
  • Illumina, Inc.
  • Ortho Corporation
  • QIAGEN
  • Quest Diagnostics Incorporated
  • Quidel
  • Revvity
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermofisher Scientific, Inc.
  • Abacus Dx
  • Amavita Heart
  • Co-Diagnostics, Inc.
  • Cyted Health
  • Diatech Pharmacogenetics
  • Diesse Diagnostica Senese
  • Element Biosciences
  • Fapon Biotech
  • Fujirebio
  • Geneoscopy, Inc.
  • Immucor
  • LifeLabs
  • Microbix Biosystems Inc.
  • PathAI Diagnostics
  • Platomics
  • SeqOne
  • SpinChip Diagnostics ASA
  • Stilla Technologies
  • UltraDx Bio
  • Vascular Health
  • American Association of Bioanalysts (AAB)
  • American Association for Clinical Chemistry (AACC)
  • American Association of Endocrinologists (AAE)
  • American Association of Medical Colleges (AAM)
  • Association of British HealthTech Industries (ABHI)
  • American Heart Association (AHA)
  • American Health Information Management Association (AHIMA)
  • American Medical Diagnostics Industry Association (AMDIS)
  • Association for Molecular Pathology (AMP)
  • American Medical Technology Society (AMTS)
  • American Society for Clinical Pathology (ASCP)
  • American Society of Echocardiography (ASE)
  • ASTM International
  • British Standards Institution (BSI)
  • Clinical Laboratory Management Association (CLMA)
  • Clinical and Laboratory Standards Institute (CLSI)
  • Canadian Medical Association (CMA)
  • Canadian Medical Laboratory Association (CMLA)
  • Computerized Physician Order Entry (CPOE)
  • Council of State and Territorial Epidemiologists (CSTE)
  • European Centre for Disease Prevention and Control (ECDC)
  • European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)
  • European Hematology Association (EHA)
  • European Laboratory Network (ELN)
  • European Laboratory Safety Association (ELSA)
  • European Society of Cardiology (ESC)
  • European Society of Human Reproduction and Embryology (ESHRE)
  • European Union of Laboratory Medicine (EULIS)
  • Florida International Medical Expo (FIME)
  • Healthcare Information and Management Systems Society (HIMSS)
  • International Federation of Biomedical Laboratory Science (IFBLS)
  • International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)
  • International Society for Biological and Environmental Repositories (ISBER)
  • Laboratory Developed Tests (LDT) Association
  • Laboratory of Government Chemists (LGC)
  • National Association of County and City Health Officials (NACCHO)
  • National Association of Chain Drug Stores (NACDS)
  • National Association of Community Health Centers (NACRC)
  • National Association of Testing Authorities (NAT)
  • National Coalition for Adult Immunization (NCA)
  • National Committee for Clinical Laboratory Standards (NCCLS)
  • National Cardiovascular Data Registry (NCDR)
  • National Community Pharmacists Association (NCPA)
  • National Committee for Quality Assurance (NCQA)
  • National Diagnostic Association (NDA)
  • National Healthcare Corporation (NHC)
  • National Health Service (NHS)
  • National Health Service Corps (NHSC)
  • National Institute on Aging (NIA)
  • National Institutes of Health (NIH)
  • National Medical Laboratory Association (NMLA)
  • National Safety Council (NSC)
  • National Society of Genetic Counselors (NSGC)
  • Professional Association of Medical Laboratory Scientists (PAML)
  • Pan American Health Organization (PAP)
  • Pathology & Clinical Laboratory Science (PCLS)
  • Public Health Genomics Foundation (PHG Foundation)
  • Precision Medicine Partnership Alliance (PMP)
  • Society of Biologics Organizations (SBO)
  • Society for Clinical Chemistry (SCC)
  • Society of Critical Care Medicine (SCCM)
  • Society for In Vitro Biology (SIB)
  • Society of Immunology and Cell Biology (SIC)
  • Society for Immunotherapy of Cancer (SIS)
  • Society for Laboratory Automation and Screening (SLA)
  • Society for Laboratory Automation and Screening (SLAS)
  • Society for Medical Laboratory Science (SMLA)
  • Society of Nuclear Medicine and Molecular Imaging (SNMMI)
  • Standards of Practice Association (SOP)
  • Value-Based Care Association (VBC)
  • World Association of Societies of Pathology and Laboratory Medicine (WAS)
  • World Health Organization (WHO)
  • World Laboratory Association of Biomedical Laboratories (WLAB)

Related Topics

Related Reports

In Vitro Diagnostics Market, Industry Trends and Global Forecasts to 2035: Distribution by Test Type, Type of Offering, Type of Technology, Therapeutic Area, End Users and Geographical Regions - Product Image

In Vitro Diagnostics Market, Industry Trends and Global Forecasts to 2035: Distribution by Test Type, Type of Offering, Type of Technology, Therapeutic Area, End Users and Geographical Regions

  • Report
  • 188 Pages
  • Global
From
U.S. In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Services), By Technology (Immunoassay, Molecular Diagnostics), By Application (Infectious Disease), By Test Location, By End Use, And Segment Forecasts, 2025 - 2030 - Product Image

U.S. In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Services), By Technology (Immunoassay, Molecular Diagnostics), By Application (Infectious Disease), By Test Location, By End Use, And Segment Forecasts, 2025 - 2030

  • Report
  • 358 Pages
  • United States
From
In-Vitro Diagnostic Market - North America and Country Analysis: Focus on Product, Test Type, Application, End User, and Country Analysis - Analysis and Forecast, 2025-2035 - Product Image

In-Vitro Diagnostic Market - North America and Country Analysis: Focus on Product, Test Type, Application, End User, and Country Analysis - Analysis and Forecast, 2025-2035

  • Report
  • North America
From
Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (November 4-5, 2025) - Product Image

Introduction to the In-Vitro Diagnostic Regulation (IVDR) Training Course (November 4-5, 2025)

  • Training
  • 2 Days
  • Global
In-Vitro Diagnostics (IVD) Quality Control Market Report 2025 - Product Image

In-Vitro Diagnostics (IVD) Quality Control Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.